The Latest Breaking News from OGN

S&P 500, Nasdaq Nab Best Weeks Since November: Stock Market Today

Strong gains in mega-cap tech stocks buoyed the Nasdaq on Friday, but the Dow and S&P 500 weren't so resilient.

Kiplinger · Apr 10

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 billion, beating the Wall Street estimate of $1.56 billion.

Benzinga · Nov 10, 2025

High-Yield Healthcare: 3 Stocks With Strong Dividends

This article covers three healthcare stocks that offer dividend yields of at least 7% and dives deeper into the fundamentals to determine if they're good buys.

MarketBeat · Feb 16, 2025

Are These 3 Pharma Stocks a Buy or Hold Opportunity for December?

The pharmaceutical industry looks well-positioned for long-term growth. So, let us analyze pharma stocks Procaps Group (PROC), Voyager Therapeutics (VYGR) and Organon & Co. (OGN) to identify whether they are a Buy or Hold. Read on.

StockNews.com · Dec 1, 2023

Under $15 Bargains: 3 Pharma Stocks to Watch

The pharmaceutical industry is anticipated to remain resilient, owing to increasing healthcare expenditure. Given this backdrop, it could be wise to watch quality pharma stocks Organon & Co. (OGN), GoodRx Holdings (GDRX), and Viatris (VTRS) trading under $15 now. Read on….

StockNews.com · Nov 17, 2023

3 Pharma Stocks Ready to Shine This Week

The pharmaceutical industry is expected to thrive, driven by the increasing need for chronic disease management and the requirements of an aging demographic. Given the industry’s solid prospects, quality pharma stocks Organon (OGN), GoodRx Holdings (GDRX), and Collegium Pharmaceutical (COLL) could be solid buys this week. Read on….

StockNews.com · Oct 10, 2023

Top 3 Pharma Stocks With Promising Prospects for October

The pharmaceutical sector is expected to grow rapidly in the coming years, owing to rising worldwide medical needs. Given the industry’s solid prospects, investors could consider buying quality pharma stocks such as Eagle Pharmaceuticals (EGRX), Organon (OGN), and Collegium Pharmaceutical (COLL) this month. Read on.

StockNews.com · Oct 5, 2023

"X-Men meets Attack on Titan" in West African mythology inspired OGN The Asiri

YouNeek Studios returns to Dark Horse for The Asiri Vol. 1, a new sci-fi/fantasy superhero story

GamesRadar · Jun 13, 2023

A simple device could prevent thousands of maternal deaths. Why did it take so long to get to market?

Alydia Health's Jada system for postpartum hemorrhage took 11 years to reach the market; being a women's health product made its road tougher.

Fortune · Dec 28, 2022

3 Red-Hot Healthcare Stocks Ignoring the Market's Downtrend

Despite bearish market sentiment, the healthcare industry has outperformed the broader market thanks to its defensive nature. Given overwhelming demand and the need for global healthcare development, we think the stocks of quality healthcare companies Cigna (CI), Organon (OGN), and Bristol-Myers Squibb (BMY) could be solid bets now. These stocks…

StockNews.com · Jun 1, 2022